Skip to main content
. 2023 Aug 4;4(9):556–564. doi: 10.1016/j.hroo.2023.07.008

Table 3.

Hemodynamic changes

Sham (n = 4) PVC-SC (n = 8) PVC-LC (n = 4)
LVEDP (mm Hg)
 Baseline 11.8 ± 1.5 11 ± 0.8 12.5 ± 0.9
 Week 12 10.7 ± 0.6 11.2 ± 0.7 11 ± 0.5
LVESP (mm Hg)
 Baseline 81.6 ± 6.1 73.8 ± 1 80.7 ± 2.2
 Week 12 85.7 ± 3 69.4 ± 4∗ 79.3 ± 3.3
dP/dt max (mm Hg/s)
 Baseline 984.8 ± 92.3 973.6 ± 42.1 1070.7 ± 60.7
 Week 12 1147 ± 130.3 768.2 ± 65∗† 820.8 ± 68†
dP/dt min (mm Hg/s)
 Baseline –1201.2 ± 93.1 –1159.4 ± 52.7 –1353.5 ± 67.5
 Week 12 –1492.5 ± 146.4 –880.6 ± 95.6∗† –1125.25 ± 58.7†

Values are given as mean ± SEM.

Multiple comparison test (P <.05): ∗vs sham; †vs baseline.

dP/dt max = left ventricular contractility; dP/dt min = lusitropy; LVEDP = left ventricular end-diastolic pressure; LVESP = left ventricular end-systolic pressure; other abbreviations as in Table 1.